Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

Status Completed

Clinical Trial Summary

Infantile hemangioma (IH) is the most common benign vascular tumor in pediatric population. Oral propranolol is the treatment of choice for complicated hemangiomas. Topical timolol, a non-selective beta-blocker, is an emerging treatment which has been reported to be effective and safe for the treatment of IH, especially for superficial hemangiomas. Investigators hypothesize that treatment with topical timolol in the first two months of life, before the proliferative phase or in early proliferative phase, may prevent from further growing and the need to treat with oral propranolol.

Clinical Trial Description

A multicentric, randomized, double-blind, placebo-controlled, phase II clinical trial to evaluate the efficacy and safety of 0.5% timolol maleate solution for the early treatment of infantile hemangioma.

Patients with less of 60 days of life with focal or segmental hemangiomas, superficial, mixed or abortive will be treated with topical timolol 0.5% twice a day for 24 weeks.

Changes in lesion size, color and thickness will be evaluated from photographs taken at 2,4,8,12,24 and 36 weeks. Vital signs and side effects will be recorded at each visit. Response to treatment will be evaluated by a blinded investigator in a semiquantitative scale (complete resolution, improve, stabilization, worsening). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02731287
Study type	Interventional
Source	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact
Status	Completed
Phase	Phase 2
Start date	March 2014
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01685398` - Topical Timolol for Superficial Infantile Hemangioma	Phase 3
Withdrawn	`NCT00974129` - A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas	N/A
Completed	`NCT00374335` - Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas	N/A
Recruiting	`NCT03331744` - Clinical Characteristics of Infantile Hemangioma
Completed	`NCT02342275` - Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma	Phase 3
Completed	`NCT00433940` - Immune Suppression Of Infants Treated With Steroids	N/A
Completed	`NCT04065217` - The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial	N/A
Terminated	`NCT01743885` - Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma	Phase 3
Terminated	`NCT00555464` - Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas	Phase 2
Completed	`NCT00394888` - Hemangioma Associated With High Rates of Morbidity	N/A
Completed	`NCT05327309` - Role of Propranolol as Compared to Bleomycin in Management of Hemangioma	N/A
Completed	`NCT02145884` - Topical Timolol Gel for the Treatment of Infantile Hemangiomas	Phase 2
Completed	`NCT04077515` - Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma	Phase 4
Recruiting	`NCT01147601` - Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas	Phase 0
Completed	`NCT01908972` - The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma	Phase 4
Completed	`NCT00540566` - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed	`NCT00001417` - Direct Injection of Alcohol for the Treatment of Spinal Tumors	N/A
Completed	`NCT00004436` - Randomized Study of Hormonal Regulation of Infantile Hemangioma	N/A
Recruiting	`NCT02496013` - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB	Phase 1
Completed	`NCT01072045` - Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma	Phase 2